Key Takeaways Novo Nordisk has sued rival Eli Lilly, alleging the company used deceptive advertising to promote its GLP-1 medications by comparing higher doses of Lilly’s products with lower doses of Novo Nordisk’s competing drugs while omitting more recent clinical evidence. The lawsuit, filed July 21, 2026, in the U.S. District Court for the District […]
Key Takeaways Novo Nordisk has sued rival Eli Lilly, alleging the company used deceptive advertising to promote its GLP-1 medications by comparing higher doses of Lilly’s products with lower doses of Novo Nordisk’s competing drugs while omitting more recent clinical evidence. The lawsuit, filed July 21, 2026, in the U.S. District Court for the District […]
